FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040802654> ?p ?o ?g. }

• W2040802654 endingPage "334" @default.
• W2040802654 startingPage "315" @default.
• W2040802654 abstract "The role of noradrenergic innervation in the disease outcome of adjuvant-induced arthritis (AA) has been examined following (1) systemic administration of guanethidine and (2) local application of 6-hydroxydopamine (6-OHDA) into the lymph nodes that drain the hind limbs (DLN). Sympathetic denervation by these different neurotoxins produced directionally opposite effects on disease outcome. These conflicting findings could be explained from differential denervation of sympathetic nerves in key target tissues that result from different routes of neurotoxin administration. Alternatively, these conflicting data could be due to differences in the mechanisms by which guanethidine and 6-OHDA destroy sympathetic nerve terminals. In this study, we compared disease outcome in AA following systemic and local DLN application of 6-OHDA to determine whether the route of administration is important to the development and progression of AA. Bilateral local DLN application of 6-OHDA or vehicle was performed 1 day before injection of Freund's complete adjuvant (CFA) to induce arthritis. For systemic denervation, 6-OHDA or vehicle was given by ip injections on days 1, 3, and 5 prior to CFA challenge and then once a week. Local DLN application of 6-OHDA resulted in significant increases in dorsoplantar width in arthritic rats by 27 days following CFA treatment compared to those of non-denervated arthritic rats. In contrast, systemic denervation in arthritic rats significantly decreased dorsoplantar widths 27 days after CFA treatment compared to those in sympathetically intact arthritic animals. X-ray analysis confirmed these findings. Further, local DLN application of 6-OHDA exacerbated the disease regardless of whether the neurotoxin was administered prior to immunization with CFA or closer to the time of disease onset. Our findings indicate that the route of 6-OHDA administration for denervation of sympathetic innervation is an important parameter in determining disease outcome, presumably due to differential sympathetic denervation of target tissues that are involved in disease development and progression. 6-OHDA administration into local DLN denervated these lymph nodes, but spared sympathetic innervation of the hind limbs, a pattern of sympathetic denervation that resulted in disease exacerbation. In contrast, systemic 6-OHDA administration which denervated both the arthritic joints and the secondary lymphoid organs attenuated the severity of AA. This study supports a dual role for NA innervation in modulating the severity of AA by innervation of the arthritic joints and lymphoid organs." @default.
• W2040802654 created "2016-06-24" @default.
• W2040802654 creator A5003856552 @default.
• W2040802654 creator A5010036334 @default.
• W2040802654 creator A5014157604 @default.
• W2040802654 creator A5042408556 @default.
• W2040802654 creator A5076555743 @default.
• W2040802654 date "1999-12-01" @default.
• W2040802654 modified "2023-10-01" @default.
• W2040802654 title "Dual Role for Noradrenergic Innervation of Lymphoid Tissue and Arthritic Joints in Adjuvant-Induced Arthritis" @default.
• W2040802654 cites W1502833050 @default.
• W2040802654 cites W1510924163 @default.
• W2040802654 cites W1517315202 @default.
• W2040802654 cites W1525084629 @default.
• W2040802654 cites W1548605804 @default.
• W2040802654 cites W1576170706 @default.
• W2040802654 cites W169232275 @default.
• W2040802654 cites W1966868497 @default.
• W2040802654 cites W1967460651 @default.
• W2040802654 cites W1967860016 @default.
• W2040802654 cites W1979228858 @default.
• W2040802654 cites W1995744314 @default.
• W2040802654 cites W1998437736 @default.
• W2040802654 cites W2000991738 @default.
• W2040802654 cites W2003336162 @default.
• W2040802654 cites W2003556905 @default.
• W2040802654 cites W2005524286 @default.
• W2040802654 cites W2008354469 @default.
• W2040802654 cites W2014404573 @default.
• W2040802654 cites W2023050693 @default.
• W2040802654 cites W2031294822 @default.
• W2040802654 cites W2033669242 @default.
• W2040802654 cites W2036013539 @default.
• W2040802654 cites W2036065289 @default.
• W2040802654 cites W2041888009 @default.
• W2040802654 cites W2044008984 @default.
• W2040802654 cites W2044859009 @default.
• W2040802654 cites W2048040148 @default.
• W2040802654 cites W2048192349 @default.
• W2040802654 cites W2050824901 @default.
• W2040802654 cites W2068610695 @default.
• W2040802654 cites W2072750335 @default.
• W2040802654 cites W2075119830 @default.
• W2040802654 cites W2077815340 @default.
• W2040802654 cites W2080852683 @default.
• W2040802654 cites W2081774881 @default.
• W2040802654 cites W2093409684 @default.
• W2040802654 cites W2095069650 @default.
• W2040802654 cites W2103210336 @default.
• W2040802654 cites W2118080780 @default.
• W2040802654 cites W2123312727 @default.
• W2040802654 cites W2129730319 @default.
• W2040802654 cites W2412281571 @default.
• W2040802654 doi "https://doi.org/10.1006/brbi.1999.0564" @default.
• W2040802654 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10600219" @default.
• W2040802654 hasPublicationYear "1999" @default.
• W2040802654 type Work @default.
• W2040802654 sameAs 2040802654 @default.
• W2040802654 citedByCount "63" @default.
• W2040802654 countsByYear W20408026542012 @default.
• W2040802654 countsByYear W20408026542013 @default.
• W2040802654 countsByYear W20408026542014 @default.
• W2040802654 countsByYear W20408026542015 @default.
• W2040802654 countsByYear W20408026542016 @default.
• W2040802654 countsByYear W20408026542018 @default.
• W2040802654 countsByYear W20408026542020 @default.
• W2040802654 countsByYear W20408026542021 @default.
• W2040802654 countsByYear W20408026542022 @default.
• W2040802654 countsByYear W20408026542023 @default.
• W2040802654 crossrefType "journal-article" @default.
• W2040802654 hasAuthorship W2040802654A5003856552 @default.
• W2040802654 hasAuthorship W2040802654A5010036334 @default.
• W2040802654 hasAuthorship W2040802654A5014157604 @default.
• W2040802654 hasAuthorship W2040802654A5042408556 @default.
• W2040802654 hasAuthorship W2040802654A5076555743 @default.
• W2040802654 hasConcept C126322002 @default.
• W2040802654 hasConcept C134018914 @default.
• W2040802654 hasConcept C150903083 @default.
• W2040802654 hasConcept C207001950 @default.
• W2040802654 hasConcept C24998067 @default.
• W2040802654 hasConcept C25938499 @default.
• W2040802654 hasConcept C2776232365 @default.
• W2040802654 hasConcept C2776533406 @default.
• W2040802654 hasConcept C2776805190 @default.
• W2040802654 hasConcept C2777077863 @default.
• W2040802654 hasConcept C2779190097 @default.
• W2040802654 hasConcept C42219234 @default.
• W2040802654 hasConcept C71924100 @default.
• W2040802654 hasConcept C84393581 @default.
• W2040802654 hasConcept C86803240 @default.
• W2040802654 hasConceptScore W2040802654C126322002 @default.
• W2040802654 hasConceptScore W2040802654C134018914 @default.
• W2040802654 hasConceptScore W2040802654C150903083 @default.
• W2040802654 hasConceptScore W2040802654C207001950 @default.
• W2040802654 hasConceptScore W2040802654C24998067 @default.
• W2040802654 hasConceptScore W2040802654C25938499 @default.
• W2040802654 hasConceptScore W2040802654C2776232365 @default.
• W2040802654 hasConceptScore W2040802654C2776533406 @default.

• next